{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T03:39:53Z","timestamp":1789011593474,"version":"build-2803163510"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T00:00:00Z","timestamp":1386374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00277-013-1951-6","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T03:54:36Z","timestamp":1386302076000},"page":"479-484","source":"Crossref","is-referenced-by-count":29,"title":["Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients"],"prefix":"10.1007","volume":"93","author":[{"given":"C.","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kleber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"W\u00e4sch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Engelhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,7]]},"reference":[{"issue":"4","key":"1951_CR1","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.mayocp.2013.01.019","volume":"88","author":"JR Mikhael","year":"2013","unstructured":"Mikhael JR, Dingli D, Roy V, Reeder CB, Buadi FK, Hayman SR, Dispenzieri A, Fonseca R, Sher T, Kyle RA, Lin Y, Russell SJ, Kumar S, Bergsagel PL, Zeldenrust SR, Leung N, Drake MT, Kapoor P, Ansell SM, Witzig TE, Lust JA, Dalton RJ, Gertz MA, Stewart K, Rajkumar SV, Chanan-Khan A, Lacy MQ (2013) Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013. Mayo Clin Proc 88(4):360\u2013376","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1951_CR2","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/bcj.2011.34","volume":"1","author":"M Kleber","year":"2011","unstructured":"Kleber M, Ihorst G, Terhorst M, Koch B, Deschler B, Wasch R, Engelhardt M (2011) Comorbidity as a prognostic variable in multiple myeloma: comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score. Blood Cancer J 1(9):e35","journal-title":"Blood Cancer J"},{"key":"1951_CR3","doi-asserted-by":"crossref","unstructured":"Kleber M, Ihorst G, Gross B, Koch B, Reinhardt H, Wasch R, Engelhardt M (2013) Validation of the Freiburg Comorbidity Index in 466 Multiple Myeloma Patients and Combination With the International Staging System Are Highly Predictive for Outcome. Clin Lymphoma Myeloma Leuk","DOI":"10.1016\/j.clml.2013.03.013"},{"issue":"29","key":"1951_CR4","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1200\/JCO.2007.14.9641","volume":"26","author":"A Chanan-Khan","year":"2008","unstructured":"Chanan-Khan A, Sonneveld P, Schuster MW, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, Neuwirth R, Anderson KC, Richardson PG (2008) Analysis of herpes zoster events among bortezomib-treated patients in the phase III APEX study. J Clin Oncol 26(29):4784\u20134790","journal-title":"J Clin Oncol"},{"issue":"13","key":"1951_CR5","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2008.21.0138","volume":"27","author":"CA Dasanu","year":"2009","unstructured":"Dasanu CA, Alexandrescu DT (2009) Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma? J Clin Oncol 27(13):2293\u20132294, author reply 2294\u20132296","journal-title":"J Clin Oncol"},{"issue":"1","key":"1951_CR6","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/1055-9965.EPI-12-0815","volume":"22","author":"LA Habel","year":"2013","unstructured":"Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL, Quesenberry CP Jr, Li Y, Sadier P, Tran TN (2013) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomarkers Prev 22(1):82\u201390","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"21","key":"1951_CR7","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa070596","volume":"357","author":"DM Weber","year":"2007","unstructured":"Weber DM, Chen C, Niesvizky R, Wang M, Belch A, Stadtmauer EA, Siegel D, Borrello I, Rajkumar SV, Chanan-Khan AA, Lonial S, Yu Z, Patin J, Olesnyckyj M, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 357(21):2133\u20132142","journal-title":"N Engl J Med"},{"issue":"21","key":"1951_CR8","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1056\/NEJMoa070594","volume":"357","author":"M Dimopoulos","year":"2007","unstructured":"Dimopoulos M, Spencer A, Attal M, Prince HM, Harousseau JL, Dmoszynska A, San Miguel J, Hellmann A, Facon T, Foa R, Corso A, Masliak Z, Olesnyckyj M, Yu Z, Patin J, Zeldis JB, Knight RD (2007) Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 357(21):2123\u20132132","journal-title":"N Engl J Med"},{"issue":"1","key":"1951_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clml.2011.09.216","volume":"12","author":"M Kleber","year":"2012","unstructured":"Kleber M, Ihorst G, Udi J, Koch B, Wasch R, Engelhardt M (2012) Prognostic risk factor evaluation in patients with relapsed or refractory multiple myeloma receiving lenalidomide treatment: analysis of renal function by eGFR and of additional comorbidities by comorbidity appraisal. Clin Lymphoma Myeloma Leuk 12(1):38\u201348","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"18","key":"1951_CR10","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1182\/blood-2008-10-184135","volume":"113","author":"S Knop","year":"2009","unstructured":"Knop S, Gerecke C, Liebisch P, Topp MS, Platzbecker U, Sezer O, Vollmuth C, Falk K, Glasmacher A, Maeder U, Einsele H, Bargou RC (2009) Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom). Blood 113(18):4137\u20134143","journal-title":"Blood"},{"issue":"2","key":"1951_CR11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3816\/CLML.2010.n.019","volume":"10","author":"U Heider","year":"2010","unstructured":"Heider U, Rademacher J, Kaiser M, Kleeberg L, von Metzler I, Sezer O (2010) Decrease in CD4+ T-cell counts in patients with multiple myeloma treated with bortezomib. Clin Lymphoma Myeloma Leuk 10(2):134\u2013137","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"1951_CR12","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/320157","volume":"32","author":"M Offidani","year":"2001","unstructured":"Offidani M, Corvatta L, Olivieri A, Mele A, Brunori M, Montanari M, Rupoli S, Scalari P, Leoni P (2001) A predictive model of varicella-zoster virus infection after autologous peripheral blood progenitor cell transplantation. Clin Infect Dis 32(10):1414\u20131422","journal-title":"Clin Infect Dis"},{"key":"1951_CR13","unstructured":"Engelhardt M, Berger D, Mertelsmann R (2012) Blue Book. 4th ed. Springer Heidelberg"},{"issue":"3","key":"1951_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","volume":"369","author":"JI Cohen","year":"2013","unstructured":"Cohen JI (2013) Clinical practice: herpes zoster. N Engl J Med 369(3):255\u2013263","journal-title":"N Engl J Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1951-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1951-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1951-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T11:05:18Z","timestamp":1564916718000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1951-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,7]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1951-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,7]]}}}